WithdrawnNot Applicable

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Stopped: No participants enrolled.

United States0Started 2025-09-05

Plain-language summary

Assess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients 18 - 80 years, inclusive * Patients who present with submassive pulmonary embolism (PE) * Patients requiring thrombolytic intervention to the pulmonary vasculature * Physician decision to use the Versus™ Catheter during the treatment of the patient Exclusion Criteria: * Concurrent treatment with thrombectomy * Concurrent treatment with a catheter-directed thrombolysis device that is NOT the Versus™ Catheter * Massive pulmonary embolism (PE) * Active bleeding disorder1 * Recent cerebrovascular accident or transient ischemic attack1 * Recent neurosurgery1 * Recent intracranial trauma1 * Absolute contraindication to anticoagulation1 * BMI \> 45kg/m2 * In the opinion of the investigator, the participant is not a suitable candidate for the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Blood Clot resolution

Timeframe: Within one week of hospital admission

Physician user experience

Timeframe: Periprocedural

Trial details

NCT IDNCT06975969

SponsorLiquet Medical Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2026-02-20

View on ClinicalTrials.gov More Blood Clots trials

Who can participate

Age range

18 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.